Envista Holdings Corporation
NVSTHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeEnvista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The $3.79B market capitalization puts NVST squarely in mid-cap range for its industry. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Market Cap
$3.79B
Beta
0.89
P/E (TTM)
39.33
P/E (Fwd)
14.21
EPS (TTM)
$0.60
EPS (Fwd)
$1.66
ROE
3.1%
ROA
3.2%
Cash
$1.13B
Total Debt
$1.59B
Free CF
$267.9M
52W Change
16.0%
Annual Financials
Cash vs Debt
Where NVST stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, NVST finished 11.00% below its 150-day moving average ($25.64) and 11.21% below its 200-day moving average ($25.70). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NVST overbought or oversold?
At the October 15, 2026 close, NVST's RSI(14) was 29.4, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $1.13B in cash, though total debt stands at $1.59B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $267.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 3.1% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.2% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.57B (2022) to $2.72B (2025).
Investors considering Envista Holdings Corporation should weigh the typical risks associated with NVST's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing NVST's risk profile alongside its fundamentals and technical indicators provides a more complete picture.